[Endolymphatic therapy in the treatment of primary delimited melanoblastoma of the skin].
The results of treatment of 1128 patients with the body and extremities skin melanoma were analyzed. The increase of five-year survival index in patients with the tumor of T1-4 N0M0 stage by 11.4% was promoted by the postoperative adjuvant endolymphatic chemotherapy application. The dacarbasin endolymphatic infusion together with recombinant interferon laferon have permitted to increase the survival index of patients by 15.4%.